Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06542705 · ClinicalTrials.gov registry record · NA

Effect of Internal Brace on Outcomes Following ACL Reconstruction With BTB Autograft

A NA study of ACL Reconstruction, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT06542705: Recruiting NA study of ACL Reconstruction, sponsored by NYU Langone Health.

NCT06542705 is a NA study of ACL Reconstruction that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 90 participants, below the 111-participant average among 4 other ACL Reconstruction trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06542705, a NA study of ACL Reconstruction, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess Anterior Cruciate Ligament (ACL) healing through analyzing clinical, radiographic, functional and patient-reported outcomes following ACL reconstruction with bone-tendon-bone autograft with and without internal bracing.

Primary Outcome

The KT-1000 knee arthrometer (KT-1000) is an objective instrument to measure anterior tibial motion relative to the femur for anterior cruciate ligament (ACL) reconstruction. The side-to-side differences comparing the injured and normal extremity allow the determination of a diagnosis of increased anterior-posterior laxity. A side-to-side difference of less than 3mm at 30lb and the manual maximum is considered normal. A side-to-side difference between 3 and 5mm is considered a grey area. A side-

Conditions Studied

Interventions

  • DEVICE Arthrex Internal Brace
  • PROCEDURE ACL Reconstruction

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2025-03-17
Est. Completion 2029-03
Phase NA
NYU Langone Health

1,164 total trials

What NCT06542705 shows while recruiting

NCT06542705 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 111-participant average among 4 other ACL Reconstruction trials with a reported enrollment target (19% lower).

The record links to 1 condition, with ACL Reconstruction appearing as the primary indexed condition, and to 2 interventions - of which Arthrex Internal Brace is the first listed.

NCT06542705 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06542705 about?

NCT06542705 is a clinical study titled "Effect of Internal Brace on Outcomes Following ACL Reconstruction With BTB Autograft". The purpose of this study is to assess Anterior Cruciate Ligament (ACL) healing through analyzing clinical, radiographic, functional and patient-reported outcomes following ACL reconstruction with bone-tendon-bone autograft with and without internal bracing.

What is the current status of trial NCT06542705?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-03-17. Estimated completion is 2029-03.

What conditions does trial NCT06542705 study?

This clinical trial studies the following conditions: ACL Reconstruction.

What interventions are being tested in trial NCT06542705?

The interventions under investigation include: Arthrex Internal Brace (DEVICE), ACL Reconstruction (PROCEDURE).

Who is sponsoring clinical trial NCT06542705?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06542705 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ACL Reconstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06542705, the US trial registry maintained by the National Library of Medicine. NCT06542705 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.